Breaking News
3 hours ago
Vaibhavi M.
ANI Pharmaceuticals launches generic Isosorbide Mononitrate tablets for angina treatment following FDA approval, expanding access to affordable nitrate therapy options.
Vaibhavi M.
Plus Therapeutics gains FDA Orphan Drug Designation for REYOBIQ in pediatric malignant gliomas and ependymoma, advancing targeted radiotherapy for rare brain tumors.
Vaibhavi M.
Cue Biopharma secures $7.5M milestone from Boehringer Ingelheim for advancing CUE-501 autoimmune therapy, supporting T cell-based approach targeting pathogenic B cells.
Vaibhavi M.
Telix Pharmaceuticals appoints Maria Rivas and Bill Jellison as Non-Executive Directors to strengthen governance, financial oversight, and strategic leadership for global growth.
Vaibhavi M.